What Are the Side Effects of Radiation for Rectal Cancer?

Radiation therapy for rectal cancer causes a range of side effects that vary in timing, severity, and duration. During treatment, most people experience some combination of diarrhea, rectal pain, bowel urgency, and fatigue. After treatment ends, many of these acute symptoms fade within weeks, but longer-lasting changes to bowel function, sexual health, and urinary control can persist for months or years. The specific mix of side effects depends on the radiation technique, dose, whether chemotherapy is given at the same time, and individual factors like age and baseline pelvic health.

What Happens During Treatment

The most common acute side effects are gastrointestinal. A study tracking patient-reported symptoms week by week during combined chemoradiation found that by the fifth week of treatment, roughly 40% of patients had developed meaningful pain, bowel urgency, or tenesmus (a persistent feeling of needing to have a bowel movement) that was not present when treatment started. About 30% developed diarrhea, abdominal cramping, and mucus in their stool over the same period.¹ Most patients described their overall symptom burden as moderate rather than severe, though individual experience varied widely even among people whose doctors graded their diarrhea at the same level.

Skin irritation in the pelvic area is also common, especially with longer courses of treatment. A study comparing short-course and long-course radiation found that the total number of patients with skin reactions (dermatitis) was higher in the long-course group.² Mild bladder irritation (cystitis) can also occur during treatment, though it tends to be less prominent than the bowel symptoms.

One reassuring pattern: rectal bleeding that is present early in treatment often improves on its own as the weeks go on. About three-quarters of patients who had rectal bleeding at the start of treatment saw improvement by the third week.¹

Bowel Problems That Linger

The side effect that affects daily life the most for many survivors is long-term bowel dysfunction. Radiation damages the tissues of the rectum and anal canal in ways that do not fully heal, and surgery compounds the problem. The combination can lead to a cluster of symptoms sometimes grouped under the label “low anterior resection syndrome,” or LARS, which includes fecal incontinence, urgency, frequent bowel movements, and episodes where several bowel movements cluster together in a short window.

The numbers are striking. In one large study, radiation-treated patients were far more likely than surgery-only patients to have more than eight bowel movements per day (about 19% vs. 6%). Among those without a stoma, roughly half of the radiation group experienced incontinence for liquid stool, compared to about 15% of the surgery-only group. About half needed to wear a pad, and over 40% could not defer a bowel movement when the urge arose.³

A population-level English study confirmed a similar pattern: about 44% of patients who received preoperative radiation reported poor bowel control, compared with 33% of those who had surgery alone.⁴ Follow-up surveys from a landmark Dutch trial found that both short-course radiation and long-course chemoradiation are independent risk factors for LARS, and that even 14 years later, patients who had received radiation were more likely to have major LARS and lower quality of life.⁵

Why the Damage Persists

Radiation does not just temporarily inflame the rectal area. Histological studies show that it causes structural changes in the anal sphincter complex, including muscle atrophy and swelling, which contribute to fecal incontinence.⁶ Deeper in the pelvic floor, radiation damages blood vessels and muscle fibers. In long-term observations of patients who received standard-dose radiation, researchers found dense scar tissue wrapping around and infiltrating the irradiated muscles, disrupting their normal organization. The blood vessels in the area also suffered: arterial walls broke down, smooth muscle cells were replaced by fibrous tissue, and the vessels became leaky, causing fluid buildup and swelling.⁷

The amount of radiation that hits the anal sphincter matters. When the sphincter received a higher dose, patients had significantly worse continence scores, and the effect on sphincter control was independent of how close the tumor was to the anus.⁸ This is one reason newer radiation techniques that can shape the beam more precisely are being investigated.

Sexual Dysfunction in Men and Women

Radiation to the pelvis takes a real toll on sexual function, and this is one of the side effects patients and doctors often underestimate in pre-treatment conversations.

In men, a large study comparing radiation-plus-surgery to surgery alone found measurable drops in the ability to get an erection, maintain an erection, reach orgasm, and remain sexually active, with reductions ranging from about 7% to 16% at eight months after surgery. The effect worsened with age, and while some recovery occurred over time, it was slow and incomplete.⁹ A qualitative study found that over 90% of male participants reported sexual dysfunction after rectal cancer treatment, with erectile dysfunction being the most common complaint and inability to ejaculate a less frequent but still significant issue.¹⁰

In women, the effects center on vaginal changes. Women who received radiation reported significantly more vaginal dryness (50% vs. 24%), pain during intercourse (35% vs. 11%), and reduced vaginal size (35% vs. 6%) compared to women who had surgery without radiation.¹¹ Among sexually active patients after treatment, more than 70% experienced vaginal dryness, and over half reported painful intercourse that had worsened compared to before their cancer diagnosis.¹² These problems stem from radiation-induced fibrosis and reduced blood flow to vaginal tissues, and they can develop gradually over months to years.

The English population study put it in broader terms: about 34% of radiation-treated patients reported severe sexual difficulties, compared to about 18% of those who had surgery alone.⁴

Urinary Side Effects

Urinary problems get less attention than bowel and sexual symptoms, but they are real. One study found that daily urinary incontinence was more than four times as common in radiation-treated patients than in those who had surgery alone (about 9% vs. 2%), and that severe urinary leakage was roughly twice as common after preoperative radiation.³ ⁴ Preoperative radiation generally carries a lower risk of urinary side effects than postoperative radiation, which is one of the reasons the preoperative approach has become standard for locally advanced disease.¹³

Sacral Fractures

An underrecognized late effect of pelvic radiation is weakening of the sacrum, the large triangular bone at the base of the spine. Radiation can thin bone and reduce its blood supply, making insufficiency fractures possible even without a significant injury. One study of nearly 500 patients found that about 7% developed sacral fractures after chemoradiation, with a median time to fracture of about three and a half years. Being 60 or older, being female, and having a history of osteoporosis each independently raised the risk.¹⁴ A separate study of over 560 patients found a lower rate, around 3% at three years, but confirmed that women were at substantially higher risk than men.¹⁵

These fractures often cause lower back or buttock pain that is easy to mistake for other problems. If you have received pelvic radiation and develop persistent pelvic or sacral pain, especially in the years after treatment, it is worth raising the possibility with your doctor. A CT or MRI can usually pick up the fracture. Treatment is typically conservative (rest, pain management, and sometimes a bone-strengthening medication), though healing can be slow.

Short-Course Versus Long-Course Radiation

Rectal cancer radiation generally comes in two flavors: a short course (typically five daily sessions over one week) and a long course (usually five to six weeks of daily treatment, often combined with chemotherapy). Patients reasonably want to know whether one is gentler than the other.

On the acute side, the long course tends to cause more day-to-day symptoms during treatment. One direct comparison found higher rates of grade 1 diarrhea, grade 2 colitis, grade 1 bladder irritation, and skin reactions in long-course patients.² A randomized trial reported that early radiation toxicity was substantially higher in the chemoradiation group (about 18% vs. 3%).¹⁶

For severe and late toxicity, though, the two approaches look more similar than different. A meta-analysis pooling multiple studies found no significant differences in severe acute or late side effects between short-course radiation and long-course chemoradiation.¹⁷ The same randomized trial noted that severe late toxicity was about 10% vs. 7%, a difference that was not statistically meaningful.¹⁶ Interestingly, the English population study found that patients who received long-course chemoradiation reported better bowel control than those who received short-course radiation, though there was no difference for other outcomes.⁴

How Radiation Complicates Surgery

Radiation is almost always given before surgery for locally advanced rectal cancer, and while it shrinks tumors and improves cancer control, it also changes the tissues the surgeon has to work with. Irradiated tissue heals less well because the blood supply is compromised and fibrosis sets in. The practical concern is anastomotic leakage, where the connection the surgeon makes between the remaining bowel and the rectal stump fails to seal properly.

A study comparing outcomes across treatment groups found that both long-course and short-course radiation increased the odds of anastomotic leakage compared to surgery alone, though neither made the leaks more severe when they did occur. Short-course radiation was also associated with more perineal wound complications.¹⁸ Research examining the tissue at the surgical margins has found that higher levels of radiation injury and reduced blood vessel density at the cut edge are both linked to leak risk.¹⁹ This is why surgeons sometimes create a temporary diverting stoma (an opening in the abdomen that allows stool to bypass the new connection while it heals) after radiation-treated rectal cancer surgery.

Newer Techniques That Reduce Collateral Damage

Radiation technology has improved considerably, and one of the biggest advances for rectal cancer patients is intensity-modulated radiation therapy, or IMRT. Unlike older three-dimensional conformal techniques, IMRT shapes the radiation beam more precisely to the tumor, sparing more of the surrounding healthy bowel, bladder, and pelvic structures. A comparison found that IMRT cut the rate of moderate-or-worse gastrointestinal toxicity roughly in half compared to the older approach (30% vs. about 61%), and the rate of moderate-or-worse diarrhea dropped from about 43% to 10%.²⁰

Proton beam therapy is another option being studied. A systematic review found that dosimetric comparisons between proton therapy and conventional techniques showed reduced radiation exposure to the pelvis, bowel, and bladder with protons.²¹ Whether that dosimetric advantage translates into meaningfully fewer side effects in clinical practice is still being evaluated, and proton therapy is far less widely available and more expensive.

Managing Chronic Radiation Proctitis

Some patients develop chronic radiation proctitis, an ongoing inflammation of the rectal lining that can cause persistent rectal bleeding, pain, and mucus discharge. When bleeding becomes the main problem, the most commonly used endoscopic treatment is argon plasma coagulation (APC), a technique that uses a jet of ionized gas to cauterize the abnormal blood vessels on the rectal surface. Early studies reported that all treated patients improved, with an average of about four sessions needed and no long-term complications.²² A larger follow-up study found that APC controlled bleeding successfully in about 69% of patients. In the remaining cases where APC failed, the failures were linked to more extensive surface involvement and larger ulcerations.²³

Other medical approaches, including formalin applications, sucralfate enemas, and anti-inflammatory enemas, have been tried with limited success. APC is generally considered the preferred endoscopic option because of its relative safety and effectiveness.²⁴ For the subset of patients whose bleeding cannot be controlled endoscopically, surgical fecal diversion (creating a stoma to redirect stool away from the damaged rectum) remains a last resort.

The Second-Cancer Question

Patients sometimes worry that radiation to the pelvis might cause a new cancer years later. The evidence on this is more nuanced and more reassuring than you might expect. A large study found no overall increased risk of second primary cancer with radiation, regardless of whether the second cancer appeared inside or outside the irradiated area.²⁵ With very long follow-up (up to 31 years), a slight increase was seen outside the irradiated field, but not within it.

One consistent finding across studies is that men who receive pelvic radiation actually have a lower risk of later prostate cancer, likely because the radiation incidentally treats early prostate disease. In one analysis, radiation-treated men had roughly half the rate of second prostate cancers compared to those who did not receive radiation.²⁶ On the other hand, gynecological second cancers were more common in women who had been irradiated.²⁶ A more recent population-based study found that radiation patients had a higher risk of bladder cancer over 10 years, though the absolute numbers were small (about 1.1% vs. 0.6%).²⁷

Body Image and Emotional Well-Being

The physical side effects do not exist in a vacuum. Population studies have found that radiation survivors, both short-term and long-term, report poorer body image than those treated with surgery alone.²⁸ A prospective study tracking patients over time found that sexual dysfunction scores climbed sharply, particularly in men, and body image scores trended downward after treatment.²⁹ People dealing with fecal incontinence or urinary leakage often pull back from social activities, and the research confirms this: patients with fecal or urinary incontinence scored significantly worse on global quality of life and social function measures.³

What makes this harder is that many patients feel unprepared. Pre-treatment conversations tend to focus on tumor control and survival, with side effects discussed in vague terms. When chronic bowel dysfunction or sexual problems set in months later, patients can feel blindsided. Asking your treatment team to be specific about late effects before you begin radiation is worth the awkwardness of the conversation.

The Watch-and-Wait Scenario

An increasing number of rectal cancer patients who achieve a complete response to chemoradiation are choosing a “watch and wait” approach, skipping surgery entirely and being monitored closely instead. This avoids the surgical side effects but does not eliminate the radiation side effects. Among patients on watch-and-wait programs, about a third reported major LARS, with the most common complaints being clustering of bowel movements and fecal urgency.³⁰ That is a meaningful rate of bowel dysfunction in people who did not even undergo surgery, and it underscores that radiation alone leaves a functional footprint on the pelvis.

The Gut Microbiome Connection

Researchers have started looking at why some patients get severe diarrhea during radiation while others tolerate it relatively well, and part of the answer appears to involve the gut microbiome. A systematic review found that pelvic radiation reduces the diversity of intestinal bacteria and shifts the community composition, and that these changes are more pronounced in patients who develop diarrhea.³¹ Even more intriguing, the makeup of a patient’s gut bacteria before treatment begins appears to differ between those who will go on to develop radiation diarrhea and those who will not.³² This raises the possibility that someday a stool sample before treatment could help predict who is at highest risk, or that probiotic interventions might reduce side effects, though neither approach is ready for routine clinical use yet.

Similarly, genetic research has identified variations in specific genes that are associated with worse acute radiation reactions, suggesting that individual biology plays a role in who suffers the most.³³ These genetic and microbiome findings are still in the research phase, but they point toward a future where radiation treatment plans could be personalized based on who is most vulnerable to specific side effects.

1
PubMed. Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer
2
Middle East Journal of Cancer. A Comparison of Early Side-Effects of Short-Course and Long-Course Radiotherapy in Rectal Cancer
3
International Journal of Radiation Oncology, Biology, Physics. Late Effects on Quality of Life and Function After Radiotherapy for Rectal Cancer
4
PubMed. Functional Outcomes and Health-Related Quality of Life After Curative Treatment for Rectal Cancer: A Population-Based Cohort Study in England
5
PubMed Central. Quality of Life After Radiotherapy for Rectal and Anal Cancer
6
PubMed Central. Histological assessment of radiotherapy-induced injury in the anal canal: an exploratory study
7
Gastroenterology Report. Rectal-cancer radiotherapy damages the perineal muscle floor
8
PubMed. Fecal incontinence and radiation dose on anal sphincter in patients with locally advanced rectal cancer (LARC) treated with preoperative chemoradiotherapy
9
PubMed Central. Adjuvant Radiotherapy Is Associated With Increased Sexual Dysfunction in Male Patients Undergoing Resection for Rectal Cancer
10
PubMed Central. Men’s Experience with Sexual Dysfunction Post Rectal Cancer Treatment: A Qualitative Study
11
PubMed. Sexual function in females after radiotherapy for rectal cancer
12
PubMed Central. Pelvic radiotherapy and sexual function in women
13
PubMed Central. Urinary adverse effects of pelvic radiotherapy
14
PubMed. Fractures of the sacrum after chemoradiation for rectal carcinoma: incidence, risk factors, and radiographic evaluation
15
PubMed Central. Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course
16
British Journal of Surgery. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
17
PubMed Central. Short-Course Radiotherapy versus Long-Course Radio-Chemotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer: Meta-Analysis from a Toxicity Perspective
18
PubMed Central. Surgical complications after different therapeutic approaches for locally advanced rectal cancer
19
Gastroenterology Report. Radiation-induced injury on surgical margins: a clue to anastomotic leakage after rectal-cancer resection with neoadjuvant chemoradiotherapy?
20
PubMed Central. Acute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancer
21
PubMed Central. Systematic Review Evaluating the Effectiveness of Proton Beam Therapy Compared to Conventional Radiotherapy in Non-Metastatic Rectal Cancer
22
PubMed. Argon plasma coagulation for the treatment of hemorrhagic radiation proctitis
23
PubMed Central. Efficacy and complications of argon plasma coagulation for hemorrhagic chronic radiation proctitis
24
PubMed Central. Endoscopic management of chronic radiation proctitis
25
BJS. Risk of second primary cancer in patients treated with radiotherapy for rectal cancer
26
PubMed. Incidence of second tumors after treatment with or without radiation for rectal cancer
27
PubMed. Secondary Primary Cancer Risk After Radiation Therapy in Rectal Cancer: A Population-Based Cohort Study With Propensity Score Matching
28
PubMed. Impact of preoperative radiotherapy on general and disease-specific health status of rectal cancer survivors: a population-based study
29
PubMed. Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study
30
PubMed. Impact of radiotherapy on anorectal function in patients with rectal cancer following a watch and wait programme
31
PubMed Central. The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review
32
PubMed Central. The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical Review
33
PubMed Central. Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy